The first case of avian flu in a commercial poultry operation has been found, according to the Georgia Department of Agriculture.
bird flu hit a poultry producer in Georgia, the nation’s top state for chicken production. The state Department of Agriculture announced Friday that the agency has detected a case of Highly Pathogenic Avian Influenza at a commercial poultry producer in ...
ATLANTA — The president of the Georgia Poultry Federation says until the supply of eggs rebounds, the cost may remain high for consumers. “Right now, the impact on egg prices is a classic equation of supply and demand,” said Georgia Poultry Federation President Mike Giles.
Georgia has confirmed the first positive case of the highly pathogenic avian influenza, also known as bird flu, in a commercial poultry operation, according to Georgia Agriculture Commissioner Tyler Harper.
Unless you work in agriculture, your chances of exposure to bird flu in Georgia are low, but here are a few ways to stay safe.
State agencies are issuing avian influenza (HPAI) precautions after detection of the virus in locations they manage. Although the chance of encountering a diseased animal—even less of catching or transmitting it—the safety steps are simple and procedures most readers likely already follow.
The first case of Highly Pathogenic Avian Influenza (HPAI) in a commercial poultry operation in Georgia has been confirmed, leading to the suspension of all in-state poultry events. A 6.2-mile ...
For the first time during the 2022-25 highly pathogenic avian influenza (HPAI) outbreak, the presence of the virus has been confirmed in a commercial poultry flock in Georgia.
Bird flu has wreaked havoc on the egg market. In November and December alone, 17.2 million egg-laying hens died as a result of the virus. That’s nearly half of all birds killed by the virus in 2024, according to the USDA. And it will take months to replace those flocks.
COVID-19 hospitalization was twice as likely than that for flu, especially in the first year of the study, in summer, and among those aged 65 years or older.
A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report in Science.